Please use this identifier to cite or link to this item:
Title: Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs
Authors: Popovic Djordjevic J.
Quispe, Cristina
Giordo R.
Kostić, Aleksandar Ž.
Katanić Stanković, Jelena S.
TSOUH FOKOU, Patrick Valere
carbone, katya
Martorell, Miquel
Kumar, Manoj
Pintus G.
Sharifi-Rad, Javad
Docea, Anca Oana
Cǎlina D.
Issue Date: 2022
Abstract: The human immunodeficiency virus (HIV) is responsible for acquired immune deficiency syndrome (AIDS), one of the major pandemic diseases. Highly active antiretroviral therapy (HAART) is the standard HIV-treatment regimen that usually comprises a combination of three or more antiretroviral drugs. HIV reverse transcriptase inhibitors are the main HAART target, which involves the use of both nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). However, compounds affecting other aspects of HIV replication, such as virus entry and fusion or important viral enzymes, such as integrases and proteases, have also been developed. Natural compounds from different sources, like plants, microbial and marine organisms, showed promising anti-HIV activities to the point of establishing the basis for developing new drugs. Indeed, natural compounds-based therapies have the potential to become more efficient than conventional HAART, with less or no side effects. This review aims to gather and discuss the current information about the anti-HIV activity of natural and synthetic compounds, their history and mechanism of action as well as the role of plants and their bioactive compounds as a source of new anti-HIV drugs.
Type: review
DOI: 10.1016/j.ejmech.2022.114217
ISSN: 0223-5234
SCOPUS: 2-s2.0-85125775750
Appears in Collections:Institute for Information Technologies, Kragujevac

Page views(s)




Files in This Item:
File Description SizeFormat 
  Restricted Access
29.86 kBAdobe PDFThumbnail

Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.